How to Help Your Patients Find Quillichew ER in Stock

The ongoing ADHD stimulant shortage has turned medication access into a significant clinical and administrative challenge. For patients who depend on Quillichew ER — the only long-acting chewable methylphenidate available — finding the medication in stock can feel nearly impossible. As their provider, you're in a unique position to help.

This guide provides practical, actionable strategies your practice can use to reduce the burden on patients and maintain treatment continuity during the Quillichew ER shortage.

Understanding Why Quillichew ER Is Hard to Find

Before implementing solutions, it helps to understand the specific barriers affecting Quillichew ER:

• Single manufacturer: Quillichew ER is produced solely by Tris Pharma with no generic equivalent, creating a vulnerable supply chain
• Schedule II constraints: DEA production quotas limit annual output of methylphenidate products regardless of demand
• Low pharmacy stocking rates: Because many insurance plans don't cover Quillichew ER (or require prior authorization), pharmacies order less of it — leading to faster stockouts when demand spikes
• Regional variation: Availability varies significantly by geography; a pharmacy 20 miles away may have stock when local pharmacies don't

For more clinical background, see our companion article: Quillichew ER shortage: What providers and prescribers need to know in 2026.

Strategy 1: Verify Pharmacy Stock Before Prescribing

One of the most effective things you can do is confirm availability before sending a prescription. This saves patients from the demoralizing experience of arriving at a pharmacy only to be turned away.

How to do this efficiently:

• Use MedFinder for Providers to check real-time pharmacy availability by zip code
• Have your MA or front desk staff call the patient's preferred pharmacy before the appointment ends
• Keep a running list of pharmacies in your area that have recently had Quillichew ER in stock

This small step can dramatically reduce patient frustration and no-fill rates.

Strategy 2: Build a Pharmacy Network

Establishing relationships with pharmacies — especially independent pharmacies and hospital outpatient pharmacies — can give your practice an edge during shortages:

• Identify 3–5 pharmacies in your area that regularly stock or can order Quillichew ER
• Communicate directly with pharmacy managers. Let them know you have patients who need Quillichew ER and ask about their ordering schedule
• Consider specialty pharmacies that focus on hard-to-find medications
• Don't overlook mail-order options: Some insurance-affiliated mail-order pharmacies maintain larger inventory of brand-name medications

Share this pharmacy list with your patients and keep it updated as availability changes.

Strategy 3: Streamline Prior Authorization

Prior authorization is one of the biggest obstacles to Quillichew ER access. Many insurers require PA for this brand-name product, and delays can cause patients to go days or weeks without medication.

Best practices:

• Submit PA proactively: Don't wait for the pharmacy to trigger the PA process. Submit it at the time of prescribing
• Pre-document medical necessity: In your chart notes, document why Quillichew ER is specifically needed (e.g., "Patient is 7 years old with significant pill aversion; unable to swallow capsules or tablets. Previous trial of [medication] was unsuccessful.")
• Use peer-to-peer review strategically: If a PA is denied, request a peer-to-peer review promptly. Having detailed documentation ready makes these reviews more efficient
• Create templates: Develop PA letter templates specific to Quillichew ER that your staff can quickly customize for each patient

Strategy 4: Have a Backup Medication Plan

For every patient on Quillichew ER, establish a documented backup plan in the chart. This allows for rapid switching when supply is interrupted:

• First-line backup: Quillivant XR (methylphenidate ER oral suspension) — same drug class, no pills to swallow
• Second-line backup: Ritalin LA or Aptensio XR (capsules that can be opened and sprinkled on food)
• Third-line backup: Vyvanse chewable tablets (different stimulant class — requires dose re-evaluation)

Document the backup plan, including approximate equivalent doses, so any provider in your practice can execute the switch quickly if needed.

Strategy 5: Educate Patients and Families

Empowered patients are more successful at navigating shortages. Share these resources with your patients:

• MedFinder — for checking pharmacy availability
• How to find Quillichew ER in stock near you — patient-friendly tips
• How to save money on Quillichew ER — savings programs and coupons
• Tris Pharma Co-pay Savings Card at coupon.trisadhd.com — may reduce copays to $25

Consider creating a one-page handout for your waiting room or patient portal that consolidates these resources.

Strategy 6: Leverage Your EHR

Your electronic health record system can support shortage management:

• Flag Quillichew ER patients: Use a problem list tag, medication note, or patient registry to identify all patients on Quillichew ER so you can proactively reach out during acute shortages
• Set up prescription alerts: Configure alerts for when Quillichew ER prescriptions are not picked up or not filled, which may indicate a supply issue
• Document backup plans: Store each patient's alternative medication plan in a standardized location so any provider can access it during coverage or urgent visits

Strategy 7: Address Cost as a Barrier

Quillichew ER's cash price of $300–$450 for a 30-day supply can be prohibitive, especially when insurance coverage is limited. Help your patients access savings:

• Tris Pharma Co-pay Savings Program: Commercially insured patients may pay as little as $25. Register at coupon.trisadhd.com
• Pfizer RxPathways: Patient assistance program for uninsured or underinsured patients. Apply at pfizerrxpathways.com
• Coupon aggregators: GoodRx, SingleCare, and other discount card programs may offer some savings for cash-paying patients

For a detailed guide on savings, see: How to help patients save money on Quillichew ER: A provider's guide.

Strategy 8: Report Shortages

Provider reports help regulatory agencies understand the scope of the problem:

• Report shortages to the FDA Drug Shortage Reporting Portal
• Contribute to the ASHP Drug Shortage database
• Document shortage-related treatment changes in patient charts for continuity and insurance appeals

Workflow Summary for Your Practice

Here's a quick-reference workflow for managing Quillichew ER prescriptions during the shortage:

1. At prescribing: Verify pharmacy stock via MedFinder or phone call
2. Concurrently: Submit prior authorization with documented medical necessity
3. In the chart: Document backup medication plan with equivalent doses
4. For the patient: Provide savings card info and MedFinder link
5. Ongoing: Monitor fill status via EHR; follow up on unfilled prescriptions within 48 hours

The Bottom Line

The Quillichew ER shortage requires a proactive, system-level approach from prescribers. By verifying stock, building pharmacy relationships, streamlining prior authorizations, and empowering patients with tools and resources, you can significantly reduce the impact of the shortage on your patients' ADHD treatment. Visit MedFinder for Providers to get started.